Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - TOTAL ASSETS
Total Assets KALV - KalVista Pharmaceuticals, Inc.
235 M
LAST VALUE
7.45%
2 YEAR CAGR
14.79%
5 YEAR CAGR
37.00%
10 YEAR CAGR